These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28791306)

  • 41. Epigallocatechin gallate and mitochondria-A story of life and death.
    Oliveira MR; Nabavi SF; Daglia M; Rastrelli L; Nabavi SM
    Pharmacol Res; 2016 Feb; 104():70-85. PubMed ID: 26731017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Green tea polyphenol epigallocatechin-3-gallate improves epithelial barrier function by inducing the production of antimicrobial peptide pBD-1 and pBD-2 in monolayers of porcine intestinal epithelial IPEC-J2 cells.
    Wan ML; Ling KH; Wang MF; El-Nezami H
    Mol Nutr Food Res; 2016 May; 60(5):1048-58. PubMed ID: 26991948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of monodisperse epigallocatechin gallate (EGCG) microparticles by spray drying for high antioxidant activity retention.
    Fu N; Zhou Z; Jones TB; Tan TT; Wu WD; Lin SX; Chen XD; Chan PP
    Int J Pharm; 2011 Jul; 413(1-2):155-66. PubMed ID: 21554936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas.
    Fang JY; Lee WR; Shen SC; Huang YL
    J Dermatol Sci; 2006 May; 42(2):101-9. PubMed ID: 16423506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property.
    Onoue S; Ochi M; Yamada S
    Int J Pharm; 2011 May; 410(1-2):111-3. PubMed ID: 21419204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System.
    Ho CH; Chu PY; Peng SL; Huang SC; Lin YH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy.
    Karimi-Shahri M; Alalikhan A; Hashemian P; Hashemzadeh A; Javid H
    Nanotechnology; 2023 Mar; 34(21):. PubMed ID: 36535007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of blue light irradiation on the stability of phospholipid molecules in the presence of epigallocatechin-3-gallate.
    Pires F; Geraldo VPN; Antunes A; Marletta A; Oliveira ON; Raposo M
    Colloids Surf B Biointerfaces; 2019 May; 177():50-57. PubMed ID: 30708310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
    Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
    Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The challenge of developing green tea polyphenols as therapeutic agents.
    Huo C; Wan SB; Lam WH; Li L; Wang Z; Landis-Piwowar KR; Chen D; Dou QP; Chan TH
    Inflammopharmacology; 2008 Oct; 16(5):248-52. PubMed ID: 18815735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of debranched starch nanoparticles by ionic gelation for encapsulation of epigallocatechin gallate.
    Liu Q; Cai W; Zhen T; Ji N; Dai L; Xiong L; Sun Q
    Int J Biol Macromol; 2020 Oct; 161():481-491. PubMed ID: 32534085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective role of epigallocatechin-3-gallate in health and disease: A perspective.
    Chowdhury A; Sarkar J; Chakraborti T; Pramanik PK; Chakraborti S
    Biomed Pharmacother; 2016 Mar; 78():50-59. PubMed ID: 26898424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.
    Sang S; Lee MJ; Hou Z; Ho CT; Yang CS
    J Agric Food Chem; 2005 Nov; 53(24):9478-84. PubMed ID: 16302765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of processing on physicochemical characteristics and bioefficacy of β-lactoglobulin-epigallocatechin-3-gallate complexes.
    Lestringant P; Guri A; Gülseren I; Relkin P; Corredig M
    J Agric Food Chem; 2014 Aug; 62(33):8357-64. PubMed ID: 25077960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine.
    Chao J; Lau WK; Huie MJ; Ho YS; Yu MS; Lai CS; Wang M; Yuen WH; Lam WH; Chan TH; Chang RC
    Neurosci Lett; 2010 Jan; 469(3):360-4. PubMed ID: 20026175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
    Li Z; Ha J; Zou T; Gu L
    Food Funct; 2014 Jun; 5(6):1278-85. PubMed ID: 24741679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
    Zu YG; Yuan S; Zhao XH; Zhang Y; Zhang XN; Jiang R
    Yao Xue Xue Bao; 2009 May; 44(5):525-31. PubMed ID: 19618731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.